News summary

Longevity Supplement Improved Blood Vessels in a Human Trial

Source: Lifespan.io • Published: 06 Nov 2026, 13:15

Summarized by Masters of Longevity from Lifespan.io.

Randomized trial found NOVOS Core improved vascular function and systolic blood pressure.

Longevity Supplement Improved Blood Vessels in a Human Trial
Key Takeaways
  • NOVOS Core improved endothelial function by about 2.9 percentage points.
  • Arterial stiffness was reduced, lowering pulse wave velocity by 1.18 m/s.
  • Systolic blood pressure fell by roughly 6 mmHg with the supplement.
Read the full article at Lifespan.io ↗

Continue exploring

Recommended MoL Picks

MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.